journal article·2020-09Open access

Endosomal Escape of Polymer‐Coated Silica Nanoparticles in Endothelial Cells

Alessandro Parodi, Michael Evangelopoulos, Noemi Arrighetti, Armando Cevenini, Megan Livingston, Sm Z. Khaled, Brandon S. Brown, Iman K. Yazdi, Francesca Paradiso, Jocelyn N. Campa‐Carranza, Alessandro De Vita, Francesca Taraballi, Ennio Tasciotti

Small· Volume 16· Issue 36

Abstract

Abstract Current investigations into hazardous nanoparticles (i.e., nanotoxicology) aim to understand the working mechanisms that drive toxicity. This understanding has been used to predict the biological impact of the nanocarriers as a function of their synthesis, material composition, and physicochemical characteristics. It is particularly critical to characterize the events that immediately follow cell stress resulting from nanoparticle internalization. While reactive oxygen species and activation of autophagy are universally recognized as mechanisms of nanotoxicity, the progression of these phenomena during cell recovery has yet to be comprehensively evaluated. Herein, primary human endothelial cells are exposed to controlled concentrations of polymer‐functionalized silica nanoparticles to induce lysosomal damage and achieve cytosolic delivery. In this model, the recovery of cell functions lost following endosomal escape is primarily represented by changes in cell distribution and the subsequent partitioning of particles into dividing cells. Furthermore, multilamellar bodies are found to accumulate around the particles, demonstrating progressive endosomal escape. This work provides a set of biological parameters that can be used to assess cell stress related to nanoparticle exposure and the subsequent recovery of cell processes as a function of endosomal escape.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Regenerative Medicine Program Houston Methodist Research Institute Houston TX 77030 USA

Orthopedics & Sports Medicine Houston Methodist Hospital Houston TX 77030 USA

Institute of Molecular Medicine Sechenov First Moscow State Medical University Moscow 119991 Russia

Molecular Pharmacology Unit Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori Milan 20133 Italy

Department of Molecular Medicine and Medical Biotechnology University of Naples Federico II Naples 80131 Italy

CEINGE‐Biotecnologie Avanzate S.C.R.L. Napoli NA 80145 Italy

Osteoncology and Rare Tumors Center Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS Meldola 47014 Italy

Funding

Cancer Prevention and Research Institute of Texas · Cullen Foundation · Huntington Medical Research Institutes

References (44)

Show source-provided references
1. 10.1038/s41565-018-0185-010.1038/s41565-018-0185-0 ↗
2. Maimon O. · 2008
3. 10.1186/1743-8977-9-2010.1186/1743-8977-9-20 ↗
4. Tanguay R. · 2014 · 766
5. 10.1016/j.biomaterials.2015.02.07010.1016/j.biomaterials.2015.02.070 ↗
6. 10.1093/toxsci/kfm24010.1093/toxsci/kfm240 ↗
7. 10.1016/j.jfda.2014.01.00510.1016/j.jfda.2014.01.005 ↗
8. 10.1016/j.biomaterials.2016.01.05210.1016/j.biomaterials.2016.01.052 ↗
9. 10.1016/S0169-409X(01)00202-210.1016/S0169-409X(01)00202-2 ↗
10. 10.2533/chimia.1997.3410.2533/chimia.1997.34 ↗
11. 10.1073/pnas.92.16.729710.1073/pnas.92.16.7297 ↗
12. 10.1002/smll.20120200110.1002/smll.201202001 ↗
13. 10.1039/C8NR03171A10.1039/C8NR03171A ↗
14. 10.1002/jat.347010.1002/jat.3470 ↗
15. 10.1038/nnano.2012.21210.1038/nnano.2012.212 ↗
16. 10.1016/j.biomaterials.2014.08.02410.1016/j.biomaterials.2014.08.024 ↗
17. 10.1016/j.addr.2015.10.01110.1016/j.addr.2015.10.011 ↗
18. 10.1016/j.nano.2009.08.00110.1016/j.nano.2009.08.001 ↗
19. 10.1021/acsnano.8b0515110.1021/acsnano.8b05151 ↗
20. 10.1016/j.addr.2011.11.01210.1016/j.addr.2011.11.012 ↗
21. 10.1002/mrm.2128010.1002/mrm.21280 ↗
22. 10.3390/antiox902009410.3390/antiox9020094 ↗
23. 10.1016/j.tcb.2016.09.00710.1016/j.tcb.2016.09.007 ↗
24. 10.1016/j.tiv.2011.06.01210.1016/j.tiv.2011.06.012 ↗
25. 10.1186/s12989-014-0050-810.1186/s12989-014-0050-8 ↗
26. 10.2147/IJN.S12359610.2147/IJN.S123596 ↗
27. 10.1038/nature0845510.1038/nature08455 ↗
28. 10.1002/wnan.145210.1002/wnan.1452 ↗
29. 10.3109/17435390.2010.53971310.3109/17435390.2010.539713 ↗
30. 10.1091/mbc.11.1.25510.1091/mbc.11.1.255 ↗
31. 10.1038/s41565-020-0643-310.1038/s41565-020-0643-3 ↗
32. 10.1002/jbm.a.3501710.1002/jbm.a.35017 ↗
33. 10.1002/smll.20120193910.1002/smll.201201939 ↗
34. 10.2174/138945011566614101511391410.2174/1389450115666141015113914 ↗
35. 10.2217/nnm.15.13310.2217/nnm.15.133 ↗
36. 10.1016/j.nano.2015.05.00510.1016/j.nano.2015.05.005 ↗
37. 10.1021/acsami.7b0576610.1021/acsami.7b05766 ↗
38. 10.2217/nnm-2016-037410.2217/nnm-2016-0374 ↗
39. 10.1038/srep3442210.1038/srep34422 ↗
40. 10.1016/j.biomaterials.2015.11.05410.1016/j.biomaterials.2015.11.054 ↗
41. 10.1038/s41598-019-55909-x10.1038/s41598-019-55909-x ↗
42. 10.1038/nmat378810.1038/nmat3788 ↗
43. 10.1016/0278-6915(86)90095-510.1016/0278-6915(86)90095-5 ↗
44. 10.1002/pmic.20130031810.1002/pmic.201300318 ↗